Advertisement

Science China Life Sciences

, Volume 58, Issue 9, pp 829–838 | Cite as

Reproductive management through integration of PGD and MPS-based noninvasive prenatal screening/diagnosis for a family with GJB2-associated hearing impairment

  • WenPing Xiong
  • DaYong Wang
  • Yuan Gao
  • Ya Gao
  • HongYang Wang
  • Jing Guan
  • Lan Lan
  • JunHao Yan
  • Liang Zong
  • Yuan Yuan
  • Wei Dong
  • SeXin Huang
  • KeLiang Wu
  • YaoShen Wang
  • ZhiLi Wang
  • HongMei Peng
  • YanPing Lu
  • LinYi Xie
  • Cui Zhao
  • Li Wang
  • QiuJing Zhang
  • Yun Gao
  • Na Li
  • Ju Yang
  • ZiFang Yin
  • Bing Han
  • Wei Wang
  • Zi-Jiang Chen
  • QiuJu Wang
Open Access
Cover Article

Abstract

A couple with a proband child of GJB2 (encoding the gap junction protein connexin 26)-associated hearing impairment and a previous pregnancy miscarriage sought for a reproductive solution to bear a healthy child. Our study aimed to develop a customized preconception-to-neonate care trajectory to fulfill this clinical demand by integrating preimplantation genetic diagnosis (PGD), noninvasive prenatal testing (NIPT), and noninvasive prenatal diagnosis (NIPD) into the strategy. Auditory and genetic diagnosis of the proband child was carried out to identify the disease causative mutations. The couple then received in-vitro-fertilization treatment, and eight embryos were obtained for day 5 biopsy. PGD was performed by short-tandem-repeat linkage analysis and Sanger sequencing of GJB2 gene. Transfer of a GJB2c.235delC heterozygous embryo resulted in a singleton pregnancy. At the 13th week of gestation, genomic DNA (gDNA) from the trio family and cell-free DNA (cfDNA) from maternal plasma were obtained for assessment of fetal chromosomal aneuploidy and GJB2 mutations. NIPT and NIPD showed the absence of chromosomal aneuploidy and GJB2-associated disease in the fetus, which was later confirmed by invasive procedures and postnatal genetic/auditory diagnosis. This strategy successfully prevented the transmission of hearing impairment in the newborn, thus providing a valuable experience in reproductive management of similar cases and potentially other monogenic disorders.

Keywords

preimplantation genetic diagnosis (PGD) noninvasive prenatal testing (NIPT) noninvasive prenatal diagnosis (NIPD) GJB2 (encoding the gap junction protein connexin 26) hearing impairment 

Supplementary material

11427_2015_4936_MOESM1_ESM.doc (98 kb)
Supplementary material, approximately 98 KB.

References

  1. 1.
    Morton CC, Nance WE. Newborn hearing screening—a silent revolution. N Engl J Med, 2006, 354: 2151–2164PubMedCrossRefGoogle Scholar
  2. 2.
    Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol, 2007, 110: 687–694PubMedCrossRefGoogle Scholar
  3. 3.
    Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol, 2015, 45: 16–26PubMedCrossRefGoogle Scholar
  4. 4.
    Liss J, Mirecka A, Kitowska K, Lukaszuk K. Preimplantaion genetic diagnosis of hearing loss with 35delG mutation in GJB2 gene — preliminary report. Otolaryngol Pol, 2011, 65: 443–446PubMedCrossRefGoogle Scholar
  5. 5.
    Wu CC, Lin SY, Su YN, Fang MY, Chen SU, Hsu CJ. Preimplantation genetic diagnosis (embryo screening) for enlarged vestibular aqueduct due to SLC26A4 mutation. Audiol Neurootol, 2010, 15: 311–317PubMedCrossRefGoogle Scholar
  6. 6.
    Moutou C GV, Coonen E, De Rycke M, Kokkali G, Renwick P, SenGupta SB, Vesela K, Traeger-Synodinos J. ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010. Hum Reprod, 2014, 29: 880–903PubMedCrossRefGoogle Scholar
  7. 7.
    Altarescu G, Eldar-Geva T, Brooks B, Zylber-Haran E, Varshaver I, Margalioth EJ, Levy-Lahad E, Renbaum P. Preimplantation genetic diagnosis (PGD) for nonsyndromic deafness by polar body and blastomere biopsy. J Assist Reprod Genet, 2009, 26: 391–397PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Meng M, Li XC, Ge HJ, Chen F, Han MY, Zhang YY, Kang DY, Xie WW, Gao ZY, Pan XY, Dai P, Chi FL, Chen SP, Liu P, Zhang CL, Cao JJ, Jiang H, Xu X, Wang W, Duan T. Noninvasive prenatal testing for autosomal recessive conditions by maternal plasma sequencing in a case of congenital deafness. Genet Med, 2014, 16: 972–976PubMedCrossRefGoogle Scholar
  9. 9.
    Huang LH, Han DM, Guo Y, Liu S, Cui XY, Mo LY, Qi B, Cai ZH, Liu H, En H, Guo LS. Audiological characteristics of infants with abnormal transient evoked otoacoustic emission and normal auditory brainstem response. Biosci Trends, 2008, 2: 211–215PubMedGoogle Scholar
  10. 10.
    Ji YB, Han DY, Lan L, Wang DY, Zong L, Zhao FF, Liu Q, Benedict- Alderfer C, Zheng QY, Wang QJ. Molecular epidemiological analysis of mitochondrial DNA12SrRNA A1555G, GJB2, and SLC26A4 mutations in sporadic outpatients with nonsyndromic sensorineural hearing loss in China. Acta Otolaryngol, 2011, 131: 124–129PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Lau TK, Chan MK, Lo PS, Chan HY, Chan WS, Koo TY, Ng HY, Pooh RK. Clinical utility of noninvasive fetal trisomy (NIFTY) test—early experience. J Matern Fetal Neonatal Med, 2012, 25: 1856–1859PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Jiang F, Ren JH, Chen F, Zhou YQ, Xie JS, Dan S, Su Y, Xie JH, Yin BM, Su W, Zhang HK, Wang W, Chai XH, Lin LH, Guo H, Li QY, Li PP, Yuan YY, Pan XY, Li YH, Liu LF, Chen HF, Xuan ZL, Chen SP, Zhang CL, Zhang HY, Tian ZM, Zhang ZY, Jiang H, Zhao LJ, Zheng WM, Li SG, Li YR, Wang J, Wang J, Zhang XQ. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics, 2012, 5: 1–11CrossRefGoogle Scholar
  13. 13.
    You YQ, Sun Y, Li XC, Li YL, Wei XM, Chen F, Ge HJ, Lan ZZ, Zhu Q, Tang Y, Wang SJ, Gao Y, Jiang FM, Song JP, Shi Q, Zhu X, Mu F, Dong W, Gao V, Jiang H, Yi X, Wang W, Gao ZY. Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease. Genet Med, 2014, 16: 594–600PubMedCrossRefGoogle Scholar
  14. 14.
    Chen SP, Ge HJ, Wang XB, Pan XY, Yao XT, Li XC, Zhang CL, Chen F, Jiang FM, Li PP, Jiang H, Zheng HC, Zhang L, Zhao LJ, Wang W, Li SG, Wang J, Wang J, Yang HM, Li YR, Zhang XQ. Haplotype-assisted accurate non-invasive fetal whole genome recovery through maternal plasma sequencing. Genome Med, 2013, 5: 1–10CrossRefGoogle Scholar
  15. 15.
    Zhang JQ, Wang P, Han B, Ding YB, Pan L, Zou J, Liu HS, Pang XZ, Liu EQ, Wang HY, Liu HY, Zhang XD, Cheng X, Feng DF, Li Q, Wang DY, Zong L, Yi YT, Tian N, Mu F, Tian G, Chen YQ, Liu GS, Zhang FX, Yi X, Yang L, Wang QJ. Newborn hearing concurrent genetic screening for hearing impairment-a clinical practice in 58,397 neonates in Tianjin, China. Int J Pediatr Otorhinolaryngol, 2013, 77: 1929–1935PubMedCrossRefGoogle Scholar
  16. 16.
    McArthur SJ, Leigh D, Marshall JT, Gee AJ, De Boer KA, Jansen RP. Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations. Prenat Diagn, 2008, 28: 434–442PubMedCrossRefGoogle Scholar
  17. 17.
    Chang LJ, Huang CC, Tsai YY, Hung CC, Fang MY, Lin YC, Su YN, Chen SU, Yang YS. Blastocyst biopsy and vitrification are effective for preimplantation genetic diagnosis of monogenic diseases. Hum Reprod, 2013, 28: 1435–1444PubMedCrossRefGoogle Scholar
  18. 18.
    Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC. The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod, 2009, 24: 1221–1228PubMedCrossRefGoogle Scholar
  19. 19.
    Ma DY, Ge HJ, Li XC, Jiang T, Chen F, Zhang YY, Hu P, Chen SP, Zhang JJ, Ji XQ, Xu X, Jiang H, Chen MF, Wang W, Xu ZF. Haplotype- based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing. Gene, 2014, 544: 252–258PubMedCrossRefGoogle Scholar
  20. 20.
    New MI, Tong YK, Yuen T, Jiang P, Pina C, Chan KC, Khattab A, Liao GJ, Yau M, Kim SM, Chiu RW, Sun L, Zaidi M, Lo YM. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. The Journal of clinical endocrinology and metabolism, 2014, 99: E1022–1030CrossRefGoogle Scholar
  21. 21.
    Xu Y, Li XC, Ge HJ, Xiao B, Zhang YY, Ying XM, Pan XY, Wang L, Xie WW, Ni L, Chen SP, Jiang WT, Liu P, Ye H, Cao Y, Zhang JM, Liu Y, Yang ZJ, Chen YW, Chen F, Jiang H, Ji X. Haplotype- based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. Genetics in medicine: official journal of the American College of Medical Genetics, 2015, doi: 10.1038/gim.2014.207Google Scholar
  22. 22.
    Yoo SK, Lim BC, Byeun J, Hwang H, Kim KJ, Hwang YS, Lee J, Park JS, Lee YS, Namkung J, Park J, Lee S, Shin JY, Seo JS, Kim JI, Chae JH. Noninvasive prenatal diagnosis of duchenne muscular dystrophy: comprehensive genetic diagnosis in carrier, proband, and fetus. Clin Chem, 2015, 61: 829–837PubMedCrossRefGoogle Scholar
  23. 23.
    Alfarawati S, Fragouli E, Colls P, Stevens J, Gutiérrez-Mateo C, Schoolcraft WB, Katz-Jaffe MG, Wells D. The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril, 2011, 95: 520–524PubMedCrossRefGoogle Scholar
  24. 24.
    Munne S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril, 2010, 94: 408–430PubMedCrossRefGoogle Scholar
  25. 25.
    Yin XY, Tan K, Vajta G, Jiang H, Tan YQ, Zhang CL, Chen F, Chen SP, Zhang CS, Pan XY, Gong C, Li XC, Lin CY, Gao Y, Liang Y, Yi X, Mu F, Zhao LJ, Peng HH, Xiong B, Zhang SP, Cheng DH, Lu GX, Zhang XQ, Lin G, Wang W. Massively parallel sequencing for chromosomal abnormality testing in trophectoderm cells of human blastocysts. Biol Reprod, 2013, 88: 1–6CrossRefGoogle Scholar
  26. 26.
    Fiorentino F, Bono S, Biricik A, Nuccitelli A, Cotroneo E, Cottone G, Kokocinski F, Michel CE, Minasi MG, Greco E. Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles. Hum Reprod. 2014, 29: 2802–2813PubMedCrossRefGoogle Scholar
  27. 27.
    Tan YQ, Yin XY, Zhang SP, Jiang H, Tan K, Li J, Xiong B, Gong F, Zhang CL, Pan XY, Chen F, Chen SP, Gong C, Lu CF, Luo KL, Gu YF, Zhang XQ, Wang W, Xu X, Vajta G, Bolund L, Yang HM, Lu GX, Du YT, Lin G. Clinical outcome of preimplantation genetic diagnosis and screening using next generation sequencing. Gigascience, 2014, 3: 1–9CrossRefGoogle Scholar
  28. 28.
    Xu YW, Chen SP, Yin XY, Shen XT, Pan XY, Chen F, Jiang H, Liang Y, Wang W, Xu X, Wang J, Zhang XQ, Zhou CQ, Wang J. Embryo Genome Profiling by Single-Cell Sequencing for Preimplantation Genetic Diagnosis in a beta-Thalassemia Family. Clin Chem, 2015, 61: 617–626PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2015

This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction

Authors and Affiliations

  • WenPing Xiong
    • 1
  • DaYong Wang
    • 1
  • Yuan Gao
    • 2
    • 3
  • Ya Gao
    • 5
  • HongYang Wang
    • 1
  • Jing Guan
    • 1
  • Lan Lan
    • 1
  • JunHao Yan
    • 2
    • 3
  • Liang Zong
    • 1
  • Yuan Yuan
    • 5
  • Wei Dong
    • 5
  • SeXin Huang
    • 2
    • 3
  • KeLiang Wu
    • 2
    • 3
  • YaoShen Wang
    • 5
  • ZhiLi Wang
    • 6
  • HongMei Peng
    • 7
  • YanPing Lu
    • 7
  • LinYi Xie
    • 1
  • Cui Zhao
    • 1
  • Li Wang
    • 1
  • QiuJing Zhang
    • 1
  • Yun Gao
    • 1
  • Na Li
    • 1
  • Ju Yang
    • 1
  • ZiFang Yin
    • 1
  • Bing Han
    • 1
  • Wei Wang
    • 5
  • Zi-Jiang Chen
    • 2
    • 3
    • 4
  • QiuJu Wang
    • 1
  1. 1.Department of Otolaryngology-Head and Neck Surgery, Chinese PLA Institute of OtolaryngologyChinese PLA General HospitalBeijingChina
  2. 2.Center for Reproductive MedicineShandong Provincial Hospital Affiliated to Shandong UniversityJinanChina
  3. 3.National Research Center for Assisted Reproductive Technology and Reproductive GeneticsJinanChina
  4. 4.The Key laboratory for Reproductive Endocrinology of Ministry of EducationJinanChina
  5. 5.BGI-ShenzhenShenzhenChina
  6. 6.Department of UltrasonographyChinese PLA General HospitalBeijingChina
  7. 7.Department of Obstetrics and GynecologyChinese PLA General HospitalBeijingChina

Personalised recommendations